Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies

被引:33
作者
Davies, TA
Kelly, LM
Jacobs, MR
Appelbaum, PC
机构
[1] Hershey Med Ctr, Dept Pathol, Hershey, PA 17033 USA
[2] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA
关键词
D O I
10.1128/JCM.38.4.1444-1448.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Agar dilution and microdilution (both in air) and E test and disk diffusion (both in air and CO2) were used to test the activity of telithromycin against 110 erythromycin-susceptible and 106 erythromycin-resistant pneumococci. The MICs at which 50 and 90% of strains are inhibited (MIC(50)s and MIC(50)s, respectively) for erythromycin-susceptible strains varied between 0.008 and 0.016 mu g/ml and 0.016 and 0.03 mu g/ml when the samples were incubated in air. By comparison, telithromycin MIC(50)s and MIC(50)s for erythromycin-resistant strains were in air 0.03 to 0.125 and 0.125 to 0.5 mu g/ml, respectively. When agar dilution was used as the reference method, essential agreement was found for 112 of 216 strains (51.9%) for microdilution, 168 of 216 (77.8%) for E test in air, and 132 of 216 (61.1%) for E test in CO2. With the exception of four strains tested by E test in CO2, all organisms were susceptible to a proposed telithromycin susceptibility breakpoint of less than or equal to 1 mu g/ml. By disk diffusion with 15-mu g telithromycin disks, all strains but one had zones of inhibition greater than or equal to 19 mm in diameter when incubated in CO2, while all strains had zone diameters of greater than or equal to 22 mm when incubated in air. Zone diameters in air were generally 4 to 5 mm larger than in CO2. By all methods, MICs and zones of all erythromycin-resistant strains occurred in clusters separated from those seen with erythromycin-susceptible strains. The results for macrolide-resistant strains with erm and mef resistance determinants were similar. The results show that (i) telithromycin is very active against erythromgrcin-susceptible and -resistant strains irrespective of macrolide resistance mechanism; (ii) susceptibility to telithromycin can be reliably tested by the agar, microdilution, E test, and disk diffusion methods; and (iii) incubation in CO, led to smaller zones by disk diffusion and higher MICs by E test, but at a susceptible MIC breakpoint of less than or equal to 1 mu g/ml and a susceptible zone diameter cutoff of greater than or equal to 19 mm in CO2, 215 of 216 strains were found to be susceptible to telithromycin.
引用
收藏
页码:1444 / 1448
页数:5
相关论文
共 24 条
  • [11] FRIEDLAND IR, 1994, NEW ENGL J MED, V331, P377, DOI 10.1056/NEJM199408113310607
  • [12] TREATMENT AND DIAGNOSIS OF INFECTIONS CAUSED BY DRUG-RESISTANT STREPTOCOCCUS-PNEUMONIAE
    JACOBS, MR
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) : 119 - 127
  • [13] Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters:: 1997 US surveillance study
    Jacobs, MR
    Bajaksouzian, S
    Zilles, A
    Lin, GR
    Pankuch, GA
    Appelbaum, PC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) : 1901 - 1908
  • [14] Critical appraisal of E test for the detection of fluoroquinolone resistance
    Jones, RN
    Erwin, ME
    Croco, JL
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (01) : 21 - 25
  • [15] Antimicrobial activity of RU-66647, a new ketolide
    Jones, RN
    Biedenbach, DJ
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 27 (1-2) : 7 - 12
  • [16] ANALYSIS OF MULTIPLY ANTIMICROBIAL-RESISTANT ISOLATES OF STREPTOCOCCUS-PNEUMONIAE FROM THE UNITED-STATES
    MCDOUGAL, LK
    FACKLAM, R
    REEVES, M
    HUNTER, S
    SWENSON, JM
    HILL, BC
    TENOVER, FC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (10) : 2176 - 2184
  • [17] GEOGRAPHIC-DISTRIBUTION OF PENICILLIN-RESISTANT CLONES OF STREPTOCOCCUS-PNEUMONIAE - CHARACTERIZATION BY PENICILLIN-BINDING PROTEIN PROFILE, SURFACE PROTEIN-A TYPING, AND MULTILOCUS ENZYME ANALYSIS
    MUNOZ, R
    MUSSER, JM
    CRAIN, M
    BRILES, DE
    MARTON, A
    PARKINSON, AJ
    SORENSEN, U
    TOMASZ, A
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) : 112 - 118
  • [18] *NAT COMM CLIN LAB, 1997, M2A6 NCCLS
  • [19] National Committee for Clinical Laboratory Standards, 1997, M7A4 NCCLS
  • [20] In vitro selection of resistance to four β-lactams and azithromycin in Streptococcus pneumoniae
    Pankuch, GA
    Jueneman, SA
    Davies, TA
    Jacobs, MR
    Appelbaum, PC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 2914 - 2918